Adimab closes Series F fundraise, gets new digs

Posted on April 3, 2012 by Patricia Resende
Read the full post by Patricia Resende on Mass High Tech Newspaper | Mass High Tech: The Voice of New England Innovation | New Hampshire.

Human antibodies discovery company Adimab LLC has closed a $13.8 million Series F round of equity financing, according to documents filed with the U.S. Securities and Exchange Commission late Monday.

This entry was posted in Mass High Tech, Media. Bookmark the permalink.